New Horizons: Novel Adrenal Regenerative Therapies

19Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

Abstract

Adrenal insufficiency requires lifelong corticoid replacement therapies. However, current therapies are not able to replace the physiological circadian pattern of the adrenal cortex and are associated with many metabolic, vascular, neuroendocrine, and mental perturbations. Therefore, regenerative and more curative strategies would be desirable. In the current perspective, we describe emerging new regenerative therapies for the treatment of adrenal insufficiency. In particular, we discuss gene therapy and cell replacement strategies. Furthermore, we discuss how adrenal cells might be used as a source for regenerative therapies of nonadrenal neurodegenerative diseases such as Parkinson disease.

Cite

CITATION STYLE

APA

Bornstein, S. R., Malyukov, M., Heller, C., Ziegler, C. G., Ruiz-Babot, G., Schedl, A., … Steenblock, C. (2020, September 1). New Horizons: Novel Adrenal Regenerative Therapies. Journal of Clinical Endocrinology and Metabolism. Endocrine Society. https://doi.org/10.1210/clinem/dgaa438

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free